Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Alvarez Mediavilla, Elena"'
Autor:
Lorvellec, Maëlle, Pellegata, Alessandro Filippo, Maestri, Alice, Turchetta, Chiara, Alvarez Mediavilla, Elena, Shibuya, Soichi, Jones, Brendan, Scottoni, Federico, Perocheau, Dany P., Cozmescu, Andrei Claudiu, Delhove, Juliette M., Kysh, Daniel, Gjinovci, Asllan, Counsell, John R., Heywood, Wendy E., Mills, Kevin, McKay, Tristan R., De Coppi, Paolo, Gissen, Paul
Publikováno v:
In iScience 18 December 2020 23(12)
Autor:
Lee, Lydia, Lim, Wen Chean, Galas-Filipowicz, Daria, Fung, Kent, Taylor, Julia, Patel, Dominic, Akbar, Zulaikha, Alvarez Mediavilla, Elena, Wawrzyniecka, Patrycja, Shome, Debarati, Reijmers, Rogier M., Gregg, Trillian, Wood, Leigh, Day, William, Cerec, Virginie, Ferrari, Mathieu, Thomas, Simon, Cordoba, Shaun, Onuoha, Shimobi, Khokhar, Nushmia, Peddareddigari, Vijay, Al-Hajj, Muhammad, Cavet, Jim, Zweegman, Sonja, Rodriguez-Justo, Manuel, Youg, Kwee, Pule, Martin, Popat, Rakesh
Publikováno v:
Lee, L, Lim, W C, Galas-Filipowicz, D, Fung, K, Taylor, J, Patel, D, Akbar, Z, Alvarez Mediavilla, E, Wawrzyniecka, P, Shome, D, Reijmers, R M, Gregg, T, Wood, L, Day, W, Cerec, V, Ferrari, M, Thomas, S, Cordoba, S, Onuoha, S, Khokhar, N, Peddareddigari, V, Al-Hajj, M, Cavet, J, Zweegman, S, Rodriguez-Justo, M, Youg, K, Pule, M & Popat, R 2023, ' Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapy ', Journal for Immunotherapy of Cancer, vol. 11, no. 6, 006699 . https://doi.org/10.1136/jitc-2023-006699
BACKGROUND: We used a proliferating ligand (APRIL) to construct a ligand-based third generation chimeric antigen receptor (CAR) able to target two myeloma antigens, B-cell maturation antigen (BCMA) and transmembrane activator and CAML interactor. MET
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10172::5cee7ec9d109561b4a182af7bd3f881d
https://research.vumc.nl/en/publications/540fb1ef-aa13-4c81-ae9c-cba4c9f3ea95
https://research.vumc.nl/en/publications/540fb1ef-aa13-4c81-ae9c-cba4c9f3ea95
Autor:
Lee L; Research Department of Haematology, UCL Cancer Institute, London, UK., Lim WC; Autolus Ltd, London, UK., Galas-Filipowicz D; Research Department of Haematology, UCL Cancer Institute, London, UK., Fung K; Research Department of Haematology, UCL Cancer Institute, London, UK., Taylor J; Autolus Ltd, London, UK., Patel D; Department of Pathology, UCL Cancer Institute, London, UK., Akbar Z; Autolus Ltd, London, UK., Alvarez Mediavilla E; Research Department of Haematology, UCL Cancer Institute, London, UK., Wawrzyniecka P; Lumicks, Amsterdam, The Netherlands., Shome D; Lumicks, Amsterdam, The Netherlands., Reijmers RM; Lumicks, Amsterdam, The Netherlands., Gregg T; Lumicks, Amsterdam, The Netherlands., Wood L; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK., Day W; Autolus Ltd, London, UK., Cerec V; Autolus Ltd, London, UK., Ferrari M; Autolus Ltd, London, UK., Thomas S; Autolus Ltd, London, UK., Cordoba S; Autolus Ltd, London, UK., Onuoha S; Autolus Ltd, London, UK., Khokhar N; Autolus Ltd, London, UK., Peddareddigari V; Autolus Ltd, London, UK., Al-Hajj M; Autolus Ltd, London, UK., Cavet J; The Christie NHS Foundation Trust, Manchester, UK., Zweegman S; Vrije Univ Amsterdam, Amsterdam, The Netherlands., Rodriguez-Justo M; Department of Pathology, UCL Cancer Institute, London, UK., Youg K; Research Department of Haematology, UCL Cancer Institute, London, UK., Pule M; Research Department of Haematology, UCL Cancer Institute, London, UK m.pule@ucl.ac.uk.; Autolus Ltd, London, UK., Popat R; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Jun; Vol. 11 (6).